Neeraja Balachander, who oversees Boehringer Ingelheim’s extensive cardio-renal-metabolic portfolio, articulated the company’s ambitious vision. “We have a program in MASH,…
Read More

Neeraja Balachander, who oversees Boehringer Ingelheim’s extensive cardio-renal-metabolic portfolio, articulated the company’s ambitious vision. “We have a program in MASH,…
Read More
A breakthrough in skeletal biology has emerged from the Institute of Science Tokyo, where researchers have identified a previously misunderstood…
Read More
In a significant advancement for aerospace engineering, researchers at the Massachusetts Institute of Technology (MIT) have successfully demonstrated a unified…
Read More
For decades, metabolic dysfunction-associated steatohepatitis (MASH), the more severe inflammatory form of fatty liver disease, was a silent epidemic, often…
Read More
Recent breakthroughs in bioengineering at the Massachusetts Institute of Technology have fundamentally altered the scientific understanding of the relationship between…
Read More
A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…
Read More
In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…
Read More
A groundbreaking study has identified a novel mechanism by which a single small molecule can leverage two distinct cellular pathways…
Read More
A pioneering research initiative led by the University of Adelaide is charting a new course for the global energy transition…
Read More
In a landmark study that redefines the biological understanding of the relationship between physical activity and neurological health, engineers at…
Read More